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  ABSTRACT 
Title: A PROSPECTIVE RANDOMIZED OPEN LABEL COMPARATIVE STUDY OF 
MONTELUKAST AND RANITIDINE AS AN ADD ON THERAPY TO CETIRIZINE IN 
CHRONIC URTICARIA 
Background: 
 Chronic urticaria is a highly distressing disease affecting a person’s life quality. In 
most cases, monotherapy fails. Hence, combinations of antihistamines with montelukast, 
H2blockers, ciclosporin, dapsone, omalizumab are used with varying results. 
Aim: 
To assess the efficacy and safety of the combination therapy of Montelukast and 
Cetirizine with Ranitidine and Cetirizine in chronic urticaria patients. 
Methodology: 
Hundred patients were recruited, randomized and medications were given to group A 
(Cetirizine+ Montelukast) and group B (Cetirizine+Ranitidine).Complete history, clinical 
examination and laboratory investigations were done at the beginning of the study. Patients 
were educated to keep a daily record of Urticaria Activity Score(UAS7)  over seven 
consecutive days in a descriptive chart. Review of patient’s UAS7 record and clinical 
examination were done at every weekend. Sum of score at the end of every week for 4 weeks 
were calculated and   recorded.  
Results: 
The mean weekly UAS in group A were 18.67, 10.07, 4.65, 1.74 and  in group B were 
27.77, 19.38, 13.68 and 8.04 respectively. Significant difference in symptom reduction 
between group A and group B was found to be favouring group A. The mean total UAS in 
group A was 35.13, group B is 68.87 (p< 0.001). 
Conclusion: 
Montelukast seems to be a promising medication as add-on therapy to Cetirizine both 
in the aspect of efficacy and safety in patients affected by chronic urticaria.  
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